Skip to main content
Log in

Considerations on the potential teratogenic effects of antiretroviral therapy

  • Clinical Evidence
  • Clinical Letters
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Murdaca G, Costantini S, Villa R, Setti M, Puppo F, Indiveri F. A case of transposition of the great arteries in a female infant of a HIV-1-infected woman. Potential teratogenic effects of antiretroviral drugs.Intern Emerg Med 2006; 1: 86–8.

    Article  PubMed  Google Scholar 

  2. Patel D, Thorne C, Fiore S, Newell ML, for the European Collaborative Study. Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women?J Acquir Immune Defic Syndr 2005; 40: 116–8.

    Article  PubMed  Google Scholar 

  3. The Antiretroviral Pregnancy Registry. Interim Report for 1 January 1989–31 July 2005. http://www.apregistry.com

  4. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. US Department of Health and Human Services. 4 May 2006. http://AIDSinfo.nih.gov

  5. Viramune [package insert]. Columbus, OH: Roxane Laboratories Inc., 2000.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alessandro Bartoloni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meli, M., Vicidomini, S. & Bartoloni, A. Considerations on the potential teratogenic effects of antiretroviral therapy. Int Emergency Med 1, 249–250 (2006). https://doi.org/10.1007/BF02934751

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02934751

Keywords

Navigation